UPDATE (12/12/19): In a 230-190 vote, the House is has passed HR 3. The legislation now moves to the Senate for consideration.
Rising prescription drug costs continue to threaten U.S. residents’ physical and financial health, leaving millions of Americans unable to afford essential medications. Nevertheless, pharmaceutical companies have continued to increase prices on critical drugs like insulin. Despite Donald Trump’s vocal campaign promises to limit prescription spending, his administration’s proposed approach does nothing to curb pharmaceutical companies’ ability to set astronomical drug prices. Democrats in the House and Senate have introduced a number of bills designed to meaningfully decrease prescription costs, some of which have bipartisan support from Republicans. Specifically, the House has introduced HR 3: the Lower Drug Costs Now Act.
A few key provisions from these bills include:
As these bills are introduced and considered, constituents must urge their representatives to support legislation to substantively control prescription drug costs.